-
Mashup Score: 0Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia - 8 month(s) ago
Key Points. Downregulation of major histocompatibility complex class II expression is observed at posttransplant pediatric AML relapse.Natural killer cells and
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Survival similar in lung transplantation for COVID-19-related ARDS, pulmonary fibrosis - 8 month(s) ago
Patients with COVID-19-related acute respiratory distress syndrome undergoing transplantation had comparable, high survival rates to patients with COVID-19-related pulmonary fibrosis, according to results published in JAMA Surgery.Further, survival rates from these patients did not differ from those of patients who underwent lung transplantation for a non-COVID-19-related reason, according to
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
ICYMI: Survival rates following lung #transplantation did not differ between those with #COVID-19 related #ARDS or pulmonary #fibrosis. https://t.co/VKPNGaneRa
-
-
Mashup Score: 3Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD - 8 month(s) ago
Key Points. Compared with classic acute GVHD, late acute GVHD presents with worse clinical severity and higher-risk biomarker parameters.Patients with late acut
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Compared with classic acute GVHD, late acute GVHD presents with worse clinical severity and higher-risk biomarker parameters. https://t.co/B29hVyuQvh #transplantation #clinicaltrialsandobservations #healthservicesandoutcomes https://t.co/01RURLN1An
-
-
Mashup Score: 1Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study - 8 month(s) ago
Key Points. An alemtuzumab population pharmacokinetic model has been developed for more accurate intravenous dosing in pediatric HSCT.Optimal exposure is associ
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An alemtuzumab population pharmacokinetic model has been developed for more accurate intravenous dosing in pediatric HSCT. https://t.co/Ot1wgV6wFn #transplantation #clinicaltrialsandobservations https://t.co/lZTHRJnLPe
-
-
Mashup Score: 2Transplantation and Surgery | AASLD - 8 month(s) ago
Filter by Core Series: Search Evidence Corner Effect of hypothermic oxygenated machine perfusion on symptomatic nonanastomotic biliary strictures in DCD livers Can machine perfusion of liver grafts improve outcomes compared to static cold storage? …
Source: www.aasld.orgCategories: Gastroenterology, Latest HeadlinesTweet-
Excited for this great new partnership between @ASTSChimera & @LiverFellow Network! 🔥 Looking forward to all the upcoming surgery & #transplantation educational content on LFN! https://t.co/bJiuEkLbbp #livertwitter #GITwitter #transplant #livertransplant https://t.co/MmfSJuPAt7
-
-
Mashup Score: 1More evidence for low-dose IL-2 for chronic GVHD in children - 8 month(s) ago
In this issue of Blood Advances, Wobma et al report that subcutaneous low-dose interleukin-2 (LD IL-2) reversed chronic graft-versus-host disease (cGVHD) manife
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
More evidence for low-dose IL-2 for chronic GVHD in children https://t.co/rjMOEbjg8d #InsideBloodAdvances #IBA #clinicatrialsandobservations #transplantation
-
-
Mashup Score: 1Endocrinology for the hepatologist : Clinical Liver Disease - 8 month(s) ago
An abstract is unavailable.
Source: journals.lww.comCategories: Gastroenterology, Latest HeadlinesTweet-
🚨AST LICOP #ManuscriptMonday🚨 #Endocrinology for the hepatologist in @CLD_Learning by Sadaf Afraz + @NikhilKapilaMD https://t.co/k6EEAcTjvt #liverwitter #transplantation #AUD https://t.co/KPxjMDf6jq
-
-
Mashup Score: 7Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD - 8 month(s) ago
Key Points. Compared with classic acute GVHD, late acute GVHD presents with worse clinical severity and higher-risk biomarker parameters.Patients with late acut
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Compared with classic acute GVHD, late acute GVHD presents with worse clinical severity and higher-risk biomarker parameters. https://t.co/B29hVyuQvh #transplantation #clinicaltrialsandobservations #healtheservicesandoutcomes https://t.co/vImv0OBrhi
-
-
Mashup Score: 1Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study - 8 month(s) ago
Key Points. An alemtuzumab population pharmacokinetic model has been developed for more accurate intravenous dosing in pediatric HSCT.Optimal exposure is associ
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An alemtuzumab population pharmacokinetic model has been developed for more accurate intravenous dosing in pediatric HSCT. https://t.co/Ot1wgV6wFn #transplantation #clinicaltrialsandobservations https://t.co/SnuvuZLpB1
-
-
Mashup Score: 8Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD - 8 month(s) ago
Key Points. Unrelated-donor PBSCT with PTCY was associated with a reduced relapse rate compared with tacrolimus-based prophylaxis (25% vs 34%; P = .027).Moderat
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Unrelated-donor PBSCT with PTCY was associated with a reduced relapse rate compared with tacrolimus-based prophylaxis (25% vs 34%; P = .027). https://t.co/LFNg7NIszH #transplantation #clinicatrialsandobservations https://t.co/aRHt4K7YUt
-
Downregulation of major histocompatibility complex class II expression is observed at posttransplant pediatric AML relapse. https://t.co/22Ztrgnv4W #immunobiologyandimmunotherapy #myeloidneoplasia #transplantation https://t.co/IDJVheTBQw